Shares of Organovo Holdings Inc. (PINK: ONVO), a company engaged in the development and commercialization of a platform technology for the generation of 3D human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs, edged higher in trading today.